Share this post on:

Product Name: FLT3 antibody [BV10A4]
Applications: FACS, IP
Predicted Target Size:
Positive Controls:
Form Supplied:
Concentration:
Purification:
Full Name: fms-related tyrosine kinase 3
Background: CD135 / FLT3, also known as FLK2 or STK-1 is a receptor tyrosine kinase that plays important roles in hematopoiesis. After binding of Flt3 ligand (FL), CD135 homodimerizes and stimulates proliferation, differentiation and protects the cell from apoptosis. The loss of CD90 and gain of CD135 expression marks the loss of self-renewal in hematopoietic stem cell population. Detectable CD135 expression appears first at low levels on the surface of primitive multilineage progenitor cells and disappears during defined stages of B-cell development, but is upregulated and maintained during maturation of monocytes. CD135 is also expressed on thymocytes, dendritic cell progenitors and on mature dendritic cells, as well as on various malignant hematopoietic cells.Entrez Gene (human): 13q12
Synonyms: CD135, FLK2, STK1
Cellular Localization:
CAS NO: 1799948-06-3
ICG-001
Host: Mouse
Clonality: Monoclonal
Isotype: IgG1
Immunogen: BV-173 leukemic cell line
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4
Storage Instruction: Store at 2-8°C. Do not use after expiration date stamped on vial label. For long-term storage aliquot and store at -20°C. Avoid freeze/thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: The mouse monoclonal antibody BV10A4 (BV10) reacts with CD135 (FLT3, FLK2, STK-1), a 130-160 kDa type III receptor tyrosine kinase that is involved in early steps of hematopoiesis.
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/21862622?dopt=Abstract

Share this post on: